Impact of antiviral treatment and hospital admission delay on risk of death associated with 2009 A/H1N1 pandemic influenza in Mexico

BMC Infectious Diseases

Volumn 12, Issue , 2012, Pages

  Chowell, Gerardo ^a,b   Viboud, Cécile ^b   Simonsen, Lone ^b,c   Miller, Mark A ^b   Echevarría Zuno, Santiago ^d   González León, Margot ^d   Borja Aburto, Víctor H ^d  

^a ARIZONA STATE UNIVERSITY   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c GEORGE WASHINGTON UNIVERSITY   (United States)

^d INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

2009 A H1N1 influenza pandemic; Antivirals; Case fatality ratio; Hospital admission delay; Mexico.; Multivariate logistic regression; Neuraminidase inhibitors; Pandemic wave

Indexed keywords

OSELTAMIVIR; SIALIDASE INHIBITOR; ZANAMIVIR;

2009 H1N1 INFLUENZA; ADULT; AGE; ANTIVIRAL THERAPY; ARTICLE; CASE FATALITY RATIO; DISEASE SEVERITY; FATALITY; FEMALE; GENDER; GEOGRAPHIC DISTRIBUTION; HOSPITAL ADMISSION; HOSPITAL ADMISSION DELAY; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEXICO; MORTALITY; OUTPATIENT; PANDEMIC;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MEXICO; MIDDLE AGED; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84862222780     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-12-97     Document Type: Article

References (51)

1. Louie JK, Acosta M, Winter K, Jean C, Gavali S, Schechter R, Vugia D, Harriman K, Matyas B, Glaser CA, et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA 2009, 302(17):1896-1902. 10.1001/jama.2009.1583, 19887665.
2. Dominguez-Cherit G, Lapinsky SE, Macias AE, Pinto R, Espinosa-Perez L, de la Torre A, Poblano-Morales M, Baltazar-Torres JA, Bautista E, Martinez A, et al. Critically Ill patients with 2009 influenza A(H1N1) in Mexico. JAMA 2009, 302(17):1880-1887. 10.1001/jama.2009.1536, 19822626.
3. Investigators AI, Webb S, Pettilä V, Seppelt I, Bellomo R, Bailey M, Cooper D, Cretikos M, Davies A, Finfer S, et al. Critical Care Services and 2009 H1N1 Influenza in Australia and New Zealand. N Engl J Med 2009, 361(20):1925-1934.
4. Jain S, Kamimoto L, Bramley AM, Schmitz AM, Benoit SR, Louie J, Sugerman DE, Druckenmiller JK, Ritger KA, Chugh R, et al. Hospitalized Patients with 2009 H1N1 Influenza in the United States, April-June 2009. N Engl J Med 2009,
5. Van Kerkhove MD, Vandemaele KA, Shinde V, Jaramillo-Gutierrez G, Koukounari A, Donnelly CA, Carlino LO, Owen R, Paterson B, Pelletier L, et al. Risk Factors for Severe Outcomes following 2009 Influenza A (H1N1) Infection: A Global Pooled Analysis. PLoS Med 2011, 8(7):e1001053. 10.1371/journal.pmed.1001053, 3130021, 21750667.
6. Charu V, Chowell G, Palacio Mejia LS, Echevarría-Zuno S, Borja-Aburto VH, Simonsen L, Miller MA, Viboud C. Mortality Burden of the A/H1N1 Pandemic in Mexico: A Comparison of Deaths and Years of Life Lost to Seasonal Influenza. Clin Infect Dis 2011, 985-993.
7. Chowell G, Echevarría-Zuno S, Viboud C, Simonsen L, Tamerius J, Miller MA, Borja-Aburto VH. Characterizing the Epidemiology of the 2009 Influenza A/H1N1 Pandemic in Mexico. PloS Med 2011, 8(5):e1000436. 10.1371/journal.pmed.1000436, 3101203, 21629683.
8. Echevarria-Zuno S, Mejia-Arangure JM, Mar-Obeso AJ, Grajales-Muniz C, Robles-Perez E, Gonzalez-Leon M, Ortega-Alvarez MC, Gonzalez-Bonilla C, Rascon-Pacheco RA, Borja-Aburto VH. Infection and death from influenza A H1N1 virus in Mexico: a retrospective analysis. Lancet 2009, 374(9707):2072-2079. 10.1016/S0140-6736(09)61638-X, 19913290.
9. Centers for Disease Control and Prevention (CDC) Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR Morb Mortal Wkly Rep 2009, 58(19):521-524.
10. Instituto Mexicano del Seguro Social. Direccion de Prestaciones Medicas. Division de Excelencia Clinica Guia de Referencia Rapida. Prevencion, Diagnostico y tratamiento de la influenza A/H1N1 Website: www.imss.gob.mx, published: 04/28/2009 (updated: 9/17/2009). www.imss.gob.mx, Instituto Mexicano del Seguro Social. Direccion de Prestaciones Medicas. Division de Excelencia Clinica.
11. Gilca R, De Serres G, Boulianne N, Ouhoummane N, Papenburg J, Douville-Fradet M, Fortin E, Dionne M, Boivin G, Skowronski DM. Risk factors for hospitalization and severe outcomes of 2009 pandemic H1N1 influenza in Quebec, Canada. Influenza Other Respi Viruses 2011, 5(4):247-255. 10.1111/j.1750-2659.2011.00204.x, 21651735.
12. Campbell A, Rodin R, Kropp R, Mao Y, Hong Z, Vachon J, Spika J, Pelletier L. Risk of severe outcomes among patients admitted to hospital with pandemic (H1N1) influenza. CMAJ 2010, 182(4):349-355. 10.1503/cmaj.091823, 2831689, 20159893.
13. Higuera Iglesias AL, Kudo K, Manabe T, Corcho Berdugo AE, Corrales Baeza A, Alfaro Ramos L, Guevara Gutierrez R, Manjarrez Zavala ME, Takasaki J, Izumi S, et al. Reducing occurrence and severity of pneumonia due to pandemic H1N1 2009 by early oseltamivir administration: a retrospective study in Mexico. PLoS One 2011, 6(7):e21838. 10.1371/journal.pone.0021838, 3132754, 21760915.
14. Hanshaoworakul W, Simmerman JM, Narueponjirakul U, Sanasuttipun W, Shinde V, Kaewchana S, Areechokechai D, Levy J, Ungchusak K. Severe human influenza infections in Thailand: oseltamivir treatment and risk factors for fatal outcome. PLoS One 2009, 4(6):e6051. 10.1371/journal.pone.0006051, 2699035, 19557130.
15. Lee N, Choi KW, Chan PK, Hui DS, Lui GC, Wong BC, Wong RY, Sin WY, Hui WM, Ngai KL, et al. Outcomes of adults hospitalised with severe influenza. Thorax 2010, 65(6):510-515. 10.1136/thx.2009.130799, 20522848.
16. McGeer A, Green KA, Plevneshi A, Shigayeva A, Siddiqi N, Raboud J, Low DE. Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada. Clin Infect Dis 2007, 45(12):1568-1575. 10.1086/523584, 18190317.
17. Kumar A. Early versus late oseltamivir treatment in severely ill patients with 2009 pandemic influenza A (H1N1): speed is life. J Antimicrob Chemother 2011, 66(5):959-963. 10.1093/jac/dkr090, 21406435.
18. Uyeki T. Antiviral treatment for patients hospitalized with 2009 pandemic influenza A (H1N1). N Engl J Med 2009, 361(23):e110. 10.1056/NEJMopv0910738, 19923564.
19. Centers for Disease Control and Prevention Updated interim recommendations for the use of antiviral medications in the treatment and prevention of influenza for the 2009-2010 season. Available 2010, http://www.cdc.gov/h1n1flu/recommendations.htm. Accessed 15 May 2011, Centers for Disease Control and Prevention.
20. World Health Organization WHO guidelines for pharmacological management of pandemic (H1N1) 2009 influenza and other influenza viruses 2010, Available: http://www.who.int/csr/resources/publications/swineflu/h1n1_guidelines_pharmaceutical_mngt.pdf. Accessed 15 May 2011, World Health Organization.
21. Coffin SE, Leckerman K, Keren R, Hall M, Localio R, Zaoutis TE. Oseltamivir shortens hospital stays of critically ill children hospitalized with seasonal influenza: a retrospective cohort study. Pediatr Infect Dis J 2011, 30(11):962-966. 10.1097/INF.0b013e318232ede9, 21997661.
22. Louie JK, Jean C, Acosta M, Samuel MC, Matyas BT, Schechter R. A review of adult mortality due to 2009 pandemic (H1N1) influenza A in California. PLoS One 2011, 6(4):e18221. 10.1371/journal.pone.0018221, 3071719, 21483677.
23. Wilking H, Buda S, von der Lippe E, Altmann D, Krause G, Eckmanns T, Haas W. Mortality of 2009 pandemic influenza A(H1N1) in Germany. Euro Surveill 2010, 15(49). pii: 19741.
24. Presanis AM, Pebody RG, Paterson BJ, Tom BD, Birrell PJ, Charlett A, Lipsitch M, Angelis DD. Changes in severity of 2009 pandemic A/H1N1 influenza in England: a Bayesian evidence synthesis. BMJ 2011, 343:d5408. 10.1136/bmj.d5408, 3168935, 21903689.
25. Liu Y, Wang W, Li X, Wang H, Luo Y, Wu L, Guo X. Geographic Distribution and Risk Factors of the Initial Adult Hospitalized Cases of 2009 Pandemic Influenza A (H1N1) Virus Infection in Mainland China. PLoS One 2011, 6(10):e25934. 10.1371/journal.pone.0025934, 3192122, 22022474.
26. Nicholson KG, Aoki FY, Osterhaus AD, Trottier S, Carewicz O, Mercier CH, Rode A, Kinnersley N, Ward P. Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group. Lancet 2000, 355(9218):1845-1850. 10.1016/S0140-6736(00)02288-1, 10866439.
27. Sato M, Hosoya M, Kato K, Suzuki H. Viral shedding in children with influenza virus infections treated with neuraminidase inhibitors. Pediatr Infect Dis J 2005, 24(10):931-932. 10.1097/01.inf.0000180976.81055.ce, 16220098.
28. Hayden FG, Treanor JJ, Fritz RS, Lobo M, Betts RF, Miller M, Kinnersley N, Mills RG, Ward P, Straus SE. Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment. JAMA 1999, 282(13):1240-1246. 10.1001/jama.282.13.1240, 10517426.
29. Choi WI, Rho BH, Lee MY. Male predominance of pneumonia and hospitalization in pandemic influenza A (H1N1) 2009 infection. BMC Res Notes 2011, 4:351. 10.1186/1756-0500-4-351, 3180473, 21906395.
30. Chowell G, Bertozzi SM, Colchero MA, Lopez-Gatell H, Alpuche-Aranda C, Hernandez M, Miller MA. Severe respiratory disease concurrent with the circulation of H1N1 influenza. N Engl J Med 2009, 361(7):674-679. 10.1056/NEJMoa0904023, 19564633.
31. Perez-Padilla R, de la Rosa-Zamboni D. Ponce de Leon S, Hernandez M, Quinones-Falconi F, Bautista E, Ramirez-Venegas A, Rojas-Serrano J, Ormsby CE, Corrales A et al: Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med 2009, 361(7):680-689. 10.1056/NEJMoa0904252, 19564631.
32. Viboud C, Miller M, Olson D, Osterholm M, Simonsen L. Preliminary Estimates of Mortality and Years of Life Lost Associated with the 2009 A/H1N1 Pandemic in the US and Comparison with Past Influenza Seasons. PLoS Curr 2010, RRN1153.
33. Baker MG, Wilson N, Huang QS, Paine S, Lopez L, Bandaranayake D, Tobias M, Mason K, Mackereth GF, Jacobs M, et al. Pandemic influenza A(H1N1)v in New Zealand: the experience from April to August 2009. Euro Surveill 2009, 14(34). pii: 19319.
34. Reed C, Angulo FJ, Swerdlow DL, Lipsitch M, Meltzer MI, Jernigan D, Finelli L. Estimates of the prevalence of pandemic (H1N1) 2009, United States, April-July 2009. Emerg Infect Dis 2009, 15(12):2004-2007. 10.3201/eid1512.091413, 3375879, 19961687.
35. Presanis AM, De Angelis D, Hagy A, Reed C, Riley S, Cooper BS, Finelli L, Biedrzycki P, Lipsitch M. The severity of pandemic H1N1 influenza in the United States, from April to July 2009: a Bayesian analysis. PLoS Med 2009, 6(12):e1000207. 10.1371/journal.pmed.1000207, 2784967, 19997612.
36. Libster R, Bugna J, Coviello S, Hijano DR, Dunaiewsky M, Reynoso N, Cavalieri ML, Guglielmo MC, Areso MS, Gilligan T, et al. Pediatric hospitalizations associated with 2009 pandemic influenza A (H1N1) in Argentina. N Engl J Med 2010, 362(1):45-55. 10.1056/NEJMoa0907673, 20032320.
37. Wu JT, Ma ES, Lee CK, Chu DK, Ho PL, Shen AL, Ho A, Hung IF, Riley S, Ho LM, et al. The infection attack rate and severity of 2009 pandemic H1N1 influenza in Hong Kong. Clin Infect Dis 2010, 51(10):1184-1191. 10.1086/656740, 3034199, 20964521.
38. Khandaker G, Dierig A, Rashid H, King C, Heron L, Booy R. Systematic review of clinical and epidemiological features of the pandemic influenza A (H1N1) 2009. Influenza Other Respi Viruses 2011, 5(3):148-156. 10.1111/j.1750-2659.2011.00199.x, 21477133.
39. Dabanch J, Perret C, Najera M, Gonzalez C, Guerrero A, Olea A, Fasce R, Morales C. Age as risk factor for death from pandemic (H1N1) 2009, Chile. Emerg Infect Dis 2011, 17(7):1256-1258. 10.3201/eid1707.101398, 3381387, 21762580.
40. Donaldson LJ, Rutter PD, Ellis BM, Greaves FE, Mytton OT, Pebody RG, Yardley IE. Mortality from pandemic A/H1N1 2009 influenza in England: public health surveillance study. BMJ 2009, 339:b5213. 10.1136/bmj.b5213, 2791802, 20007665.
41. Sugaya N, Shinjoh M, Mitamura K, Takahashi T. Very low pandemic influenza A (H1N1) 2009 mortality associated with early neuraminidase inhibitor treatment in Japan: Analysis of 1000 hospitalized children. J Infect 2011, 63(4):288-294. 10.1016/j.jinf.2011.06.008, 21722665.
42. Torres JP, O'Ryan M, Herve B, Espinoza R, Acuna G, Manalich J, Chomali M. Impact of the novel influenza A (H1N1) during the 2009 autumn-winter season in a large hospital setting in Santiago, Chile. Clin Infect Dis 2010, 50(6):860-868. 10.1086/650750, 20166819.
43. Yang Y, Sugimoto JD, Halloran ME, Basta NE, Chao DL, Matrajt L, Potter G, Kenah E, Longini IM. The transmissibility and control of pandemic influenza A (H1N1) virus. Science 2009, 326(5953):729-733. 10.1126/science.1177373, 2880578, 19745114.
44. Yu H, Liao Q, Yuan Y, Zhou L, Xiang N, Huai Y, Guo X, Zheng Y, van Doorn HR, Farrar J, et al. Effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: opportunistic retrospective study of medical charts in China. BMJ 2010, 341:c4779. 10.1136/bmj.c4779, 2947622, 20876641.
45. Doshi S, Kamimoto L, Finelli L, Perez A, Reingold A, Gershman K, Yousey-Hindes K, Arnold K, Ryan P, Lynfield R, et al. Description of Antiviral Treatment Among Adults Hospitalized With Influenza Before and During the 2009 Pandemic: United States, 2005-2009. J Infect Dis 2011, 204(12):1848-1856. 10.1093/infdis/jir648, 22013219.
46. Hernandez JE, Graingera J, Simonsen L, Collisa P, Edelmanc L, Sheridana WP. Impact of the 2009/10 influenza A (H1N1) pandemic on trends in influenza hospitalization, diagnostic testing, and treatment. Influenza Other Respi Viruses 2011, In Press.
47. Martin-Loeches I, Rodriguez A, Bonastre J, Zaragoza R, Sierra R, Marques A, Julia-Narvaez J, Diaz E, Rello J. Severe pandemic (H1N1)v influenza A infection: report on the first deaths in Spain. Respirology 2011, 16(1):78-85. 10.1111/j.1440-1843.2010.01874.x, 20946335.
48. Zarychanski R, Stuart TL, Kumar A, Doucette S, Elliott L, Kettner J, Plummer F. Correlates of severe disease in patients with 2009 pandemic influenza (H1N1) virus infection. CMAJ 2010, 182(3):257-264. 10.1503/cmaj.091884, 2826467, 20093297.
49. Gordon A, Videa E, Saborio S, Lopez R, Kuan G, Balmaseda A, Harris E. Diagnostic accuracy of a rapid influenza test for pandemic influenza A H1N1. PLoS One 2010, 5(4):e10364. 10.1371/journal.pone.0010364, 2860985, 20442773.
50. Palacios G, Hornig M, Cisterna D, Savji N, Bussetti AV, Kapoor V, Hui J, Tokarz R, Briese T, Baumeister E. Streptococcus pneumoniae coinfection is correlated with the severity of H1N1 pandemic influenza. PLoS One 2009, 4(12):e8540. 10.1371/journal.pone.0008540, 2795195, 20046873.
51. Centers for Disease Control and Prevention. Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1) - United States, May-August 2009. MMWR Morb Mortal Wkly Rep 2009, 58(38):1071-1074.